More than 50 million Americans have received at least one dose of the covid-19 vaccine Pfizer He Modern. So far a great deal of loyalty has been created towards these brands, but that is about to change with the arrival of the vaccine Johnson & Johnson.
This new vaccine has been listed as a watershed in vaccination efforts since requires a single dose instead of two applied with weeks difference. Besides no need to freeze it, Making it a better choice for rural communities or those with limited access to health and storage facilities.
While several are excited about its virtues, others have criticized this new alternative. Partly by the lack of clarity about its effectiveness and in another because on March 2 the United States Conference of Catholic Priests called for the vaccination of Johnson & Johnson because uses cells created in laboratories that are clones of fetal tissues from abortions performed in 1980.
If states do not plan how each brand’s vaccines will be distributed the result could be a nightmare of frustrated patients and wasted vaccines.
Experts specializing in health operations, data analysis and supply chain coordination of the source The conversation analyzed covid-19 vaccine distribution policies in the United States. His study shows that there is a lot of potential in a single-dose vaccine, but that criticisms of that cannot be ignored Johnson & Johnson during planning and distribution decision making.
Level of effectiveness of the J&J vaccine
The main factor complicating the acceptance of the Johnson & Johnson vaccine is that its level of effectiveness is only 66 percent, While those of Pfizer i Modern present levels of at least 90 percent.
Comparing these numbers is not that easy as clinical trials were conducted at different times. those of Pfizer i Modern were made before many of the new variants of the coronavirus and those of NOT A WORD after. consequently Johnson & Johnson has evidence that its vaccine works against the British, South African and Brazilian variants, while the other pharmaceuticals do not.
In terms of prevention of serious illness, hospitalization and death, the vaccine NOT A WORD is comparable to those of Pfizer i Modern. Given the shortage of vaccine supply it is best for patients to accept any of the three when they can.
Obvious and worrying rejection
According to a survey conducted in January by the U.S. Centers for Disease Control and Prevention (CDC), By giving him a choice between two-dose and NOT A WORD, 60 percent of participants said they preferred the former and only 7 percent said the latter.
Of those who preferred the former, 72 percent are willing to wait up to a month between doses of the single-dose vaccine.
serious consequences
In the European Union on 80 percent of the doses of the vaccine made by Astra Zeneca (Which also has a low level of effectiveness and is not approved in the United States) it is being wasted as many people, including doctors, believe it is inferior to that of Pfizer.
Strategies to make the Johnson & Johnson vaccine more acceptable:
The conversation suggests that the health authorities take the following measures based on their study:
- Inform people what vaccine they will receive how much Agenda your appointment for vaccination. This will prevent vaccines from being rejected once in places and wasting time and dose.
- Apply a single type of vaccine to each site. This will allow people to choose the location according to their preferred vaccine and last minute cancellations will be avoided. It also helps to facilitate the application process and avoid handling errors.
- Offer to people in rural areas, Where it would be more convenient to apply the vaccine NOT A WORD, the option to move a reasonable distance to places where vaccines are available Pfizer i Modern so that they do not feel compelled to consume the former. This would help decrease mistrust and give people the opportunity to make an informed choice.
- Be more transparent about the differences between the three vaccines and educating the public about the effectiveness of the Johnson & Johnson. The focus should be on taking advantage of all vaccines in order to achieve herd immunity as quickly as possible.
pmm